The demonstration of SCS deficiency, mtDNA depletion and elevation of MMA validates the Sucla2 mutant mouse as a model for SUCLA2-dependent mitochondrial disease with mtDNA depletion. This evidence concerns the gene SUCLA2 and inborn mitochondrial metabolism disorder.